PHARVARIS N V PHVS
COM · Common Stock · CUSIP N69605108
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 52.3m as of 2023-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $20.87.
Trends to Q3 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 22 |
| Q4 2022 | 26 |
| Q1 2023 | 22 |
| Q2 2023 | 22 |
| Q3 2023 | 22 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 14 | 8 |
| Q1 2023 | 6 | 9 |
| Q2 2023 | 10 | 7 |
| Q3 2023 | 9 | 9 |
Biggest buyers
| Cormorant Asset Management, LP | Added | +387.8k |
| Venrock Adviser, LLC | Added | +237.3k |
| Hudson Bay Capital Management LP | New | +77.8k |
| Y-Intercept (Hong Kong) Ltd | New | +17.6k |
| Walleye Capital LLC | Added | +10.7k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +3.0k |
| Qube Research & Technologies Ltd | New | +2.6k |
| BlackRock Inc. | Added | +2.1k |
| Schonfeld Strategic Advisors LLC | Added | +300 |
Biggest sellers
| SILVERARC CAPITAL MANAGEMENT, LLC | Sold out | -200.0k |
| FMR LLC | Reduced | -179.6k |
| Bain Capital Life Sciences Investors, LLC | Reduced | -84.1k |
| Soleus Capital Management, L.P. | Reduced | -47.9k |
| Lynx1 Capital Management LP | Sold out | -21.2k |
| MORGAN STANLEY | Reduced | -11.6k |
| UBS Group AG | Reduced | -1.2k |
| Foresite Capital Management V, LLC | Reduced | -1.0k |
| JPMORGAN CHASE & CO | Sold out | -151 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GENERAL ATLANTIC, L.P. 13G · passive investor filed 2026-08-14 | 7.6% |
| VIKING GLOBAL INVESTORS LP 13G · passive investor filed 2026-05-15 | 5.6% |
Fell to 5% or below in the last year: LSP V Cooperatieve U.A. (4.9%, 2026-07-31), Bain Capital Life Sciences Fund, L.P. (2.5%, 2026-02-17)
Insider purchases and sales in Q3 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q3 2023.
Holders, Q3 2023
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 11.17% of their portfolio | 4.8m $99.9m | Reduced -84.1k |
| GENERAL ATLANTIC, L.P. 1.42% of their portfolio | 4.4m $92.0m | Unchanged |
| venBio Partners LLC 25.24% of their portfolio | 4.3m $89.0m | Unchanged |
| Foresite Capital Management IV, LLC 43.39% of their portfolio | 3.7m $78.1m | Unchanged |
| VIKING GLOBAL INVESTORS LP 0.27% of their portfolio | 3.2m $67.5m | Unchanged |
| FMR LLC 0.01% of their portfolio | 3.2m $66.9m | Reduced -179.6k |
| Venrock Adviser, LLC 3.43% of their portfolio | 1.6m $32.6m | Added +237.3k |
| Cormorant Asset Management, LP 1.66% of their portfolio | 1.4m $28.4m | Added +387.8k |
| NOVO HOLDINGS A/S 2.05% of their portfolio | 1.3m $27.7m | Unchanged |
| 5AM Venture Management, LLC 3.53% of their portfolio | 587.6k $12.3m | Unchanged |
| Soleus Capital Management, L.P. 0.72% of their portfolio | 344.0k $7.2m | Reduced -47.9k |
| Walleye Capital LLC 0.02% of their portfolio | 81.0k $1.7m | Added +10.7k |
| Hudson Bay Capital Management LP 0.01% of their portfolio | 77.8k $1.6m | New |
| MORGAN STANLEY 0.00% of their portfolio | 33.7k $703.3k | Reduced -11.6k |
| Foresite Capital Management V, LLC 1.10% of their portfolio | 33.1k $691.7k | Reduced -1.0k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 21.6k $450.7k | Added +3.0k |
| Y-Intercept (Hong Kong) Ltd 0.04% of their portfolio | 17.6k $366.3k | New |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 11.9k $248.4k | Added +300 |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 2.6k $53.8k | New |
| BlackRock Inc. 0.00% of their portfolio | 2.3k $47.3k | Added +2.1k |
| UBS Group AG 0.00% of their portfolio | 50 $1.0k | Reduced -1.2k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |